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Abstract
Purpose: Knowledge of the pathophysiology of the irradiated skin is important to understand the tolerance and cosmetic re-
sponse of the human skin to radiation. There are limited studies on the effect of radiotherapy dosage and fraction size in induc-
ing apoptotic cell death in human skin. The expression of apoptotic biomarkers within a controlled population in different frac-
tionation schemes has also never been studied. This study aims to investigate radiation induced apoptotic cell death in human
skin cells after fractionated radiation exposure and the expression of unique biomarkers that reflect cell death or biology using
multiplexed immunoassays. Methods: Breast skin biopsies were obtained from a single individual and divided into small pieces.
Each piece was irradiated under different radiotherapy treatment fractionation schedules to a total dose of 50Gy. The irradiated
skin tissues were analysed using Tunnel, immunohistochemistry and Western blot assays for expression of apoptotic keratino-
cytes and biomarkers (p53, p21, and PCNA). Haematoxylin and eosin (H&E) immunostaining was performed to study the mor-
phological changes in the skin cells. Results: Radiation is mostly absorbed by the epidermal layers and observed to damage the
epidermal keratinocytes leading to the activation of apoptotic proteins. Apoptotic proteins (p53, p21 and PCNA) were con-
firmed to be up-regulated in radiation exposed skin cells as compared to normal skin cells with no radiation. There is strong
correlation of apoptotic protein expressions with increased radiation dosage and dose fractionation. Statistical analysis with
ANOVA revealed a significant increase of PCNA and p21 expression with increased radiation dosage and dose fractionation (p <
0.05). Immunohistochemically, 14 % (range 10.71% to 17.29%) of the keratinocytes were positive for PCNA and 22.5% (range
18.28% to 27.2%) for p21 after 2Gy of irradiation.  The most widespread, intense and uniform staining for PCNA and p21 was
observed in skin that had received 50Gy of irradiation. The maximum expression of p53 (range 37.09% to 50.91%) was reached
at 10Gy. Conclusion: Findings from this study will assist clinicians in predicting radiation induced skin toxicity with the current
changes in radiation fractionation protocols.
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Introduction
Radiation therapy (RT) is a commonly utilized modality for
the treatment of breast cancer. It is routinely employed in
breast conservation therapy. Its role as adjuvant therapy in
selected patients undergoing mastectomy for stages I and II
disease is currently evolving, and has become an essential
component of the combined modality approach for stage III
disease. Postmastectomy Radiotherapy (PMRT) to the chest
wall and to the regional lymphatics has shown to decrease
locoregional recurrence and increase survival for women
with large tumors and/or node-positive disease.1-2 However,
the risk of toxicity to skin and cosmesis must be weighed
against local and regional recurrences.
A review of literature suggests that the risk of radiation in-
duced skin damage is affected not only by individual varia-
tions in response to radiation, but also by the total dose re-
ceived and fractionation.3-7 There are also changes in post
mastectomy radiotherapy schedules from conventional radi-
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otherapy at 50Gy at 1.8 to 2Gy per week to more aggressive
schedules such as unconventional protocol.8 Changes in ra-
diotherapy practice over the years are due to the recognition
of the importance of fraction size, fraction number, total
dose and overall time for both tumour and normal tissue
reactions. However, there is very limited knowledge on the
extent of radiotherapy dose and fractionation schedules in
inducing cellular radiation response in the human skin.
The practice of radiotherapy would also greatly benefit from
the discovery of biomarkers that correlate with symptoms
and side effects pertaining to tissues within the irradiated
volume. Direct or surrogate biomarkers of radiation induced
toxicity could potentially give clinicians the ability to use
this information to individually plan patients treatments,
develop Phase I trials with molecular targeted agents in
combination with RT with more confidence regarding po-
tential side effects and/or to intervene and reduce late effects
with novel therapies directed against the signalling path-
way(s) involved in the late injury.9-10 However, the studies to
date are limited and there is a rather weak correlation be-
tween the in-vitro and clinical data. The role of cytokines
and apoptotic markers as biomarkers of radiation response to
different radiation dose and fraction size has also never been
studied.
In summary, this study aims to (1) look at radiation induced
apoptotic cell death in human skin cells after exposure to
post mastectomy treatment regimens and its relation to radi-
ation fraction size. This study also (2) explores the proteomic




Breast skin biopsies were obtained from a single individual
and divided into small pieces of 3 cm each, and were placed
into 5 batches (Batch A, B, C, D and E). Each batch under-
went a different radiotherapy treatment regimen, each re-
ceiving a total dose of 50Gy (Table 1). The human skin cell
sections are irradiated daily and after each irradiation, one
sample from each batch will be removed and stored in -80°C
freezer for biochemical analysis. Each experiment was re-
peated three times and average readings obtained.






A-conventional 25 2.0 Gy 25 fractions
B 20 2.5 Gy 20 fractions
C 10 5.0 Gy 10 fractions
D 5 10.0 Gy 5 fractions
E 1 50.0 Gy 1 fraction
F-control 1 No radiation -
*Each batch of skin tissues were irradiated under different radio-
therapy treatment regimen, each receiving a total dose of 50Gy.
The human skin cell sections are irradiated using a Gam-
macell® 40 Exactor Low Dose-Rate Research Irradiator under
different radiotherapy treatment schedules. Following irra-
diation, the skin sections were collected, fixed in 10% phos-
phate-buffered formalin for 10 hours at 4 C, dehydrated in
ascending concentration of (50%, 70%, 80%, 95% and 100%)
ethanol solution (Merck) for 45 minutes each. This was fol-
lowed by two incubations in xylene (Merck) solution for 15
minutes each. Samples were then placed onto plastic cassettes
and transferred into 60°C liquid paraffin tank (Leica) for 30
minutes. Samples were embedded and left to solidify on the
-5°C cold plate. The sections were cut into 3 µm thickness
using a microtome (Leica) and placed onto coated glass slides.
Measurement of Radiation Induced Apoptotic
keratinocytes
Hematoxylin and Eosin (H&E) staining
Apoptotic cells are morphologically distinct due to cell
shrinkage and nuclear condensation that stain darker by
Haematoxylin and Eosin (H&E). Based on these criteria,
irradiated sections were stained with H&E and apoptotic cells
were counted.
TUNNEL assay
DeadEnd TM Fluorometric TUNNEL System (Promega, Mad-
ison, WI) was used to detect apoptotic cells in tissue samples
following manufacturer’s protocol with some modifications.
In brief, tissue sections after deparaffinization and rehydra-
tion were permeabilized with Proteinase K (30 µg/mL) solu-
tion, repeated fixation and wash steps. After equilibration,
nucleotide mix and rTdT enzyme were added and DAPI
nuclear staining dye was applied as counterstaining. The
slides were mounted with cover slides and observed under
x400 magnification for TUNNEL-positive cells.
Immunohistochemistry (IHC) Analysis of apoptotic
biomarkers
Histological procedures
Serial paraffin sections of irradiated skin were dewaxed in
xylene and then hydrated in descending concentrations of
ethanol. Antigen retrieval was done by immersing the slides
in 0.01 M Tris /0.001M EDTA buffer (pH9.0) and pressure
cooked for 5 minutes. All sections were cooled under running
tap water for 10 minutes. The Dako Envision+ kit was used
for subsequent IHC steps. Briefly, endogenous peroxidase was
blocked using 3% H2O2 for 30 minutes and washed in
TBS-Tween 20 for 3 times. Non-specific binding was blocked
using the Dako Protein Block, serum-free, for 5 minutes,
followed by washes in TBS-Tween 20 for 3 times. Subse-
quently, sections were incubated with monoclonal an-
ti-active p53 (Dako and BD Transduction Lab), PCNA (Santa
Cruz) and P21 (Santa Cruz), in dilutions of 1:500 overnight
(Table 2).
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TABLE 2: List of antibodies used in immunohistochemistry procedures
Antibodies Product Code Company Clone
Primary p53 P21020 BD Transduction Laboratories Monoclonal
p53 D0-7 Dako Monoclonal
PCNA SC-56 Santa Cruz Monoclonal
p21 sc-817 Santa Cruz Monoclonal
Secondary Mouse IgG, HRP-conjugated, Dako Polyclonal
Mouse IgM, HRP-conjugated, Dako Polyclonal
Rabbit IgG, HRP-conjugated, Dako Polyclonal
After washing in TBS-Tween 20 for 3 times, the slides were
incubated in secondary mouse antibody from Dako Envision+
kit for 1 hour. The slides were washed sequentially and in-
cubated with DAB (3, 3-diaminobenzidine) for 5 minutes.
Subsequently, slides were counterstained with Gill’s III
hematoxylin, dehydrated in ascending concentrations of
ethanol, and cleared in xylene. Finally the sections were
mounted using Depex (Merck). Non-immunised mouse an-
tibody (IgG) was used for negative controls.
Briefly, tissue sectioned were screened under the microscope
and evaluated under high power field (hpf, x 200). The
stainings were visualized with an Olympus light microscope.
Histopathological evaluation
Sections of immunostained skin were evaluated under the
microscope by an experienced pathologist (Singapore General
Hospital, Singapore). The epidermal area in each biopsy
sample was measured and both total and specifically stained
keratinocyte nuclei were evaluated and counted. Since the
number of positive cells was low in the irradiated tissue, we
use the entire tissue section as reference determining the total
number of keratinocyte nuclei. The difference between
nonimmunoreactive (control) and immunoreactive (irradi-
ated) keratinocyte nuclei was clear cut and cells were scored
and the differences counted. The staining values are ex-
pressed as percentage of positive cells of the total number of
keratinocytes evaluated with the control as a reference.
The staining intensity and reaction pattern was evaluated
using the scale presented (Table 3).
Western Blot Analysis of Apoptotic biomarkers
Protein extraction from tissue culture cells
Skin tissues were minced and lysed directly in cell lysis buffer
containing 20 mM Tris-HCI (ph 7.5), 1% Triton X-100, 100
mM NaCL, 0.5% Nonide P-40 and I mg/ml protease inhibitor
cocktail. (Boehringer Mannheim, Mannheim, Germany).
Cells were solubilized by passing solution through the pipette
tip repeatedly followed by incubation on ice for 15 minutes.
Samples were then centrifuged at 4°C, 12,000g for 10 minutes
and the supernatant containing the proteins were collected.
Total cell lysates were then subjected to Western blot analy-
sis.
Determination of protein concentrations
Protein concentration of cell lysates (CLs) was determined
using Bradford protein quantification methods according to
manufacturer’s instructions. A standard curve was prepared
using bovine serum albumin (BSA) with concentrations
ranging from 0-2000 μg/ml the lysis buffer. Five and ten fold
dilutions were carried out for each sample and 4 repeats were
done for each standard or sample. 200μl of colorimetric assay
reagent was added to each well. After the 96-well plate was
incubated at 37°C for 30 minutes, protein concentrations
were assayed by measuring absorbance at 570 nm with a
reference wavelength of 690nm, using a photometric plate
reader (BIO-RAD, Benchmark PlusTM)
TABLE 3: The staining intensity and pattern was evaluated using the scale below
Staining Pattern Score
No Staining at all, or membrane staining in less than 10% of the cells 0
A faint/barely perceptible membrane staining is detected in more than 10% of the cells.  The cells are only
stained in part of their membrane
1+
A weak to moderate staining of the entire membrane is observed in more than 10% of the cells 2+
A strong staining of the entire membrane is observed in more than 10% of the cells 3+
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TABLE 4: List of antibodies used in Western Blot Analysis
Antibodies Product Code Company Clone
Primary p53 P21020 BD Transduction Laboratories monoclonal
PCNA SC-56 Santa Cruz monoclonal
p21 sc-817 Santa Cruz monoclonal














10Gy 2Gy Day 5 2.5Gy Day 4 5Gy Day 2 10Gy Day 1 --- 0.49 <0.000
30Gy 2Gy Day 15 5Gy Day 6 10Gy Day 3 --- --- 0.62 <0.000
50Gy 2GyDay 25 2.5Gy Day 20 5Gy Day 10 10Gy Day 5 50Gy Day 1 0.73 <0.000
*Nonparametric correlations of TUNNEL positive cells with different radiation fractionation are calculated. Both Pearson’s coefficient of corre-
lation (rp) and the corresponding P value are shown. All statistical tests are two-sided. In all groups, there was a statistically significant correlation
between TUNNEL positive cells and dose size fractionation. Radiation induced the formation of apoptotic cells and a noticeable increase was
observed in skin tissues that received higher radiation dosage. These findings were confirmed by TUNNEL assay. There is also a significant
(p<005) and strong correlation of apoptotic cells with increased fraction size.
Blocking, antibody incubation, washing and stripping
Equal amounts of protein samples were denatured, separated
by 12% SDS-PAGE and transferred onto nitro-cellulose
membrane by semi-dry blotting. The membrane was placed
protein side up and incubated for 2hrs in blocking solution.
Primary antibodies were diluted in 5% milk and incubated
with the membrane for 2hrs at room temperature. Secondary
antibodies were diluted in 5% milk and incubated with the
membrane for 1hr at room temperature. Following primary
and secondary antibody incubations (Table 4) membranes
were washed 5 times each time 10 minutes with 30ml wash-
ing buffer and incubated in sufficient volume of buffer di-
luted with horseradish peroxidase (HRP)-coupled secondary
antibody at room temperature for 1 hour. The membrane was
washed again with washing buffer for 5 times before incuba-
tion with Western lightning plus-ECL (Perkin Elmer) for a
minute, exposed on X-ray films (Konica Minolta) and devel-
oped.
Computerized gel densitometry
A Bio-Rad gel scanner and densitometer program (Gel-Pro ®
Analyzer version 4.5: MediaCybernetics, Maryland, USA)
was used to assess concentrations of the bands obtained by
Western blots. There were measured as total density units.
Statistical Analysis
Statistical Package for Social Sciences (SPSS), version 17.0
was the statistical tool used for data analysis. Nonparametric
methods were used for the statistical analysis using one-way
Anova (Analysis of Variance) - or Student’s t-tests. A value of
P<0.05 was considered to be statistically significant.
Results
Radiation induced apoptotic keratinocyte cell death is
dose and fraction size dependent
Increased Apoptotic keratinocyte cell count:
Since it has been proposed that keratinocytes damaged by
ionizing irradiation undergo apoptosis, we analysed the ex-
pression of apoptotic cells in the skin tissues of the volunteer
using TUNNEL assay. The skin tissues were irradiated with
different fractionation schedules. (Table 5)
Morphological changes of radiation induced apoptotic
keratinocytes
Results showed that radiation is mostly absorbed by the epi-
dermal layers and observed to damage the epidermal kerati-
nocytes leading to apoptosis. These cells had characteristic
dyskeratotic apoptotic cells with pyknotic nuclei in the irra-
diated sections. HE staining on control sections demon-
strated normal epidermal morphology (Figure 1A) while
irradiated sections demonstrated strong evidence of cellular
damage caused by ionizing radiation (Figure 1B-D).
The keratinocytes were enlarged with cytological atypia
Figure 2. The epidermis in the irradiated skin was thin, con-
taining only one to three layers of keratinocytes and in some
tissues; the epidermis layer was also detached from the dermis
layer Figure 3.
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FIG. 1: Morphological evaluation
FIG. 2 (left): Shows morphological changes in cell after layer due to the irradiation.
FIG. 3 (right): HE slide showing a detached epidermis radiation exposure.
FIG. 4: The boxplot for PCNA immunoreactitivity in different radia-
tion dosage starting from 2Gy to 50Gy. Bars represent the range
within the different radiation dosage as indicated.
Expression of apoptosis related marker proteins with
irradiation and this is dose and fraction size dependent
Accumulation of p53, PCNA and p21 proteins with increas-
ing dose
We analyzed sections of paraffin-embedded skin biopsies of
the volunteer for p53, PCNA and p21 apoptotic related
FIG. 5: The boxplot for p21 immunoreactitivity in different radiation
dosage starting from 2Gy to 50Gy. Bars represent the range within
the different radiation dosage as indicated.
marker proteins using western blot and immunohistochem-
istry analysis. Hardly any apoptotic positive cells were seen in
the control epidermis before radiation. Skin tissues were
irradiated with 2, 2.5, 5, 10 and 50 Gray. Apoptotic proteins
(PCNA, P21) were confirmed to be up-regulated in radiation
exposed skin cells as compared to normal skin cells with no
radiation. There is strong correlation of apoptotic protein
expressions with increased radiation dosage. (Figures 4-5)
A detached epidermis layer due to irradia-
tion
Cells showing cytological atypia
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In contrast, P53 expression started to increase after 2Gy of
radiation up to a maximum dose of 10Gy (Figure 6). At 2 Gy,
a higher number of cells faintly positive for p53 extended
from the suprabasal layer to the stratum granulosum. At
more superficial locations, these cells became strongly
stained by anti-p53. The maximum expression of p53 (me-
dian =44%, range 37.09% to 50.91%) was reached at 10Gy
after irradiation exposure, and in most cases the p53 immu-
noreactivity appeared to be concentrated within the kerati-
nocyte nuclei. At higher radiation dosage (> 10Gy), the epi-
dermal sections showed a downward trend in the expression
of P53. The irradiated keratinocyte nuclei appeared to be p53
negative or only faintly stained at 50Gy (median=7%, range
5.15% to 8.85%). Western blot analysis revealed similar re-
sults.
FIG. 6: The boxplot for p53 immunoreactitivity in different radiation
dosage starting from 2Gy to 50Gy. Bars represent the range within
the different radiation dosage as indicated.
Morphological changes of PCNA, P21 and P53 with increas-
ing dose
Results unequivocally demonstrated that, in response to
DNA damage, PCNA (Figure 7) and p21 (Figure 8) are
up-regulated for cell cycle arrest to facilitate DNA repair.
As for p53, we hardly detected any cells stained with an-
ti-p53 antibody in the control slide (Figure 9). P53 expres-
sion started to increase after 2Gy of irradiation and maximal
expression of p53 was reached at 10Gy. Thereafter irradiated
cells appeared to be p53 negative or only faintly stained at
50Gy.
Accumulation of p53, PCNA and p21 proteins with increas-
ing fraction size
Subsequently, we tested by immunohistochemistry the ex-
pression of marker proteins of apoptosis, namely p53, P21 and
PCNA with different radiation fractionations.
Repeated measures of ANOVA revealed that the effects of
different radiation fractionation (2Gy, 2.5Gy, 5Gy, 10Gy and
50Gy) on human skin cells were significantly different from
each other (p<0.05). There is a positive and significant corre-
lation (Pearson’s correlation r) between radiation fractiona-
tion and apoptotic protein expression (PCNA, p21 and P53),
measured at different dosage. This correlation is strongest at
higher dose (Table 6 and 7).
In summary, we have checked for associations between cy-
tokine expression, radiation dose and type of fractionation
regimen, given that both radiation and proteins expression
are important variables in mediating radiation response. Re-
sults have shown that PCNA and p21 levels were significantly
associated with dose and treatment regimen, while elevation
of p53 was significant only up to 10Gy. These results were
supported by western blot findings.
Western blot analysis revealed elevated levels of PCNA
and P21 proteins in Irradiated keratinocytes and this is
dose and fraction size dependent
Little or no immunoreactive band specific for p53, PCNA and
p21 protein was observed in the lysates of non-irradiated
control keratinocytes. Irradiated cell lysates revealed an ac-
cumulation of p53 protein which was detected at 2Gy and
peaked at 5Gy.  After 5Gy, the expression level slightly de-
clined and was not detectable at 50Gy (Figure 10).
Regarding p21 and PCNA, a weak band was seen in control
keratinocytes. Overexpression of p21 and PCNA protein was
seen which increases with radiation dosage and fractionation
(Figures 11-14).
This is one of the few studies that evaluated the difference in
cellular response due to minor variations in the protocols of
fractionation radiotherapy. For the evaluation of the effect of
changes in dose/fraction, the human skin cells irradiated
with the same total dose of 10Gy, 30 Gy and 50Gy were
grouped according to the dose/fraction given. No significant
difference in apoptotic cell death between groups of samples
irradiated by dose fraction of 2Gy and 2.5Gy could be de-
tected. However, irradiation with a higher dose/fraction of
5Gy and 10Gy resulted in a very significant elevation of
mean % apoptotic cell death expression.  Moreover, signifi-
cant changes were also found at much lower total dose of
30Gy, where the treatment was given with a high
dose/fraction of about 5Gy. Our results demonstrate that the
increase in dose of radiation per fraction had much more
impact on radiation induced apoptosis than elevation in the
total dose, which may result in worst skin outcome. Our
result is similar to previous study by Archambeau 11 who
evaluated the effect of changes in dose/fraction using a swine
skin model. Following irradiation there is a dose-dependent
loss of basal cells. The fields treated with 2Gy daily dose
fractions show no change in the basal cell density until total
doses of 20-25Gy are delivered. This period is followed by
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increasing cell loss up to 50Gy and necrosis is produced. A separate study by Raphael12 looked at the effect of radiation
fraction size on skin viscoelasticity. They also found that the increase in dose of radiation per fraction greatly increased skin
stiffness. There is an intimate relationship between radiation-dose fractionation and clinical outcome of radiation therapy.
FIG. 7: Dose series of Irradiated skin. Sections were stained with monoclonal anti-PCNA; A-Control, B- 2Gy, C-5Gy, D-10Gy, E-50Gy
FIG. 8: Dose series of Irradiated skin. Sections were stained with monoclonal anti-p21; A-Control, B- 2Gy, C-5Gy, D-10Gy, E-50Gy
FIG. 9: Dose series of Irradiated skin. Sections were stained with monoclonal anti-p53; A-Control, B- 2Gy, C-10Gy, D-50Gy
D
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10Gy 2Gy Day 5 2.5Gy Day 4 5Gy Day 2 10Gy Day 1 --- 0.59 <0.000
30Gy 2Gy Day 15 5Gy Day 6 10Gy Day 3 --- --- 0.61 <0.002
50Gy 2GyDay 25 2.5Gy Day 20 5Gy Day 10 10Gy Day 5 50Gy Day 1 0.66 <0.000














10Gy 2Gy Day 5 2.5Gy Day 4 5Gy Day 2 10Gy Day 1 --- 0.657 <0.000
30Gy 2Gy Day 15 -- 5Gy Day 6 10Gy Day 3 --- 0.523 <0.002
50Gy 2GyDay 25 2.5Gy Day 20 5Gy Day 10 10Gy Day 5 50Gy Day 1 0.634 <0.000
*Tables 6 & 7: Nonparametric correlations of PCNA and P21 immunoreactive cells with different radiation fractionations are calculated. Both
Pearson’s coefficient of correlation (rp) and the corresponding P value are shown. All statistical tests are two-sided.
FIG.10: Little or no immunoreactive band specific for p53 was observed at dose above 10Gy
FIG.11 (top) and FIG. 12 (bottom): Western blot analysis of P21 and PCNA reveals a higher level of protein with increasing fraction size at
10Gy
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FIG.13 (top) and FIG. 14 (bottom): Western blot analysis of P21 and PCNA reveals a higher level of protein with increasing fraction size at
50Gy
Discussion
The practice of radiotherapy would greatly benefit from the
understanding of apoptosis and its associated biomarkers that
correlate with radiation dose and its side effects pertaining to
tissues within the irradiated volume. This forms the basis of
our study.
In this study we demonstrated dose-dependent keratinocyte
apoptosis following irradiation that was associated with acti-
vation of apoptosis regulating biomarkers. We demonstrated
that increasing radiation dosage led to increased keratinocyte
death in human skin. Our results are in agreement with the
findings of previously reported studies showing a dose re-
lated induced apoptosis using swine skin11 and human co-
chlear cells.13 Morphological evaluation was consistent with
our findings. HE staining revealed an increased in the num-
ber of apoptotic cells with condensed nuclei surrounded by a
bright halo. These morphological changes were similar to
what has been described in Ponten F.14 The keratinocytes
were enlarged with cytologic atypia.
The relationship between the total dose of radiation and
fractionation of the dose given is also crucial in radiotherapy
with respect to the development of radiation induced effects
in normal tissues. This elevates the therapeutic ratio and
enables efficient tumour control while decreasing both early
and late radiation effects in normal tissues.12
Cellular damage caused by ionizing radiation induces pro-
duction and recruitment of specific proteins that have the
potential to predict radiation induced toxicity in tissues
within the irradiated volume.15-16 Our interest in these pro-
teins expression during Radiation Therapy is based in part on
Rubin17 and colleagues’ description of a cytokine-linked con-
tinuum of early and late radiation responses. Rubin et al
showed in murine and clinical lung models that radiation
induced fibrosis is progressive after treatment and begins
immediately following lung irradiation. Levels of IL-1, TGF
beta and TNF alpha were observed to increase in lung tissue
immediately after radiation exposure, however clinically
appreciable lung fibrosis may occur months later. A number
of clinical studies have also shown that cytokines are
elevated during and after Radiotherapy for a variety of
malignancies.10, 18-19 Using this as a feasibility study, we
measured the cytokines protein levels of p53, PCNA and p21
in human breast skin cells after receiving post-mastectomy
radiotherapy treatment regimens as biomarkers for radiation
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response. The radiation response of cytokines within a con-
trolled population with the same dose but in different frac-
tion size has never been studied before. Thus this is one of
the first studies of its kind on cytokines expression in human
breast skin after exposure to fractionated radiation.
Statistical analysis with ANOVA revealed a significant in-
crease of PCNA and p21 expression with increased radiation
dosage (p<0.05) and with different radiation fraction size
(p<0.05). Our results showed that cytokines are up-regulated
in response to radiation; and this is dependent on radiation
dosage and fraction size. This is in agreement with previous
studies that shown that these cytokines are
radiation-inducible cytokine. Fredrik Ponten et al 14 investi-
gated levels of p53 and p21 in skin exposed to different types
of radiation. Results show an early onset of increased p53
levels and a correlation between p53 and p21 was evident. In
other studies, p53, PCNA and p21 were induced in hairless
mouse epidermis following UVB radiation20, human skin
response to x-ray treatment with release of p53 21 and
induced expression of p21 and PCNA proteins in UVB
irradiated human epidermis.22 However, drawbacks of these
studies were the use of mice epidermis and UVB radiation
and included a range of radiation dose. In our study, these
factors were closely controlled. Human breast epidermis
from a single donar and 50Gy of 6 MV ionizing radiation
were used.
Results from our studies show predictable patterns of cyto-
kine expression. PCNA and P21 levels elevated gradually
from 2Gy to 10Gy, followed with a sharp increase at 50Gy.
On the other hand, p53 was elevated at 2Gy and persisted
until 10Gy, and then returned to baseline values. This pat-
tern was also consistent with increasing fraction size. Not
only did this study demonstrate the early and persistent ele-
vation of cytokine production following irradiation, but it
also determined consistent patterns of cytokines expression.
A similar pattern of cytokine expression was observed in
murine studies. Rubin17 and colleagues studied cytokine in-
duction in mice receiving thoracic irradiation. They found
several cytokines were longitudinally elevated with consis-
tent patterns between mice.
One question arising from our results is why p53 did not
exhibit similar pattern with PCNA and p21 given that all are
apoptotic inducing cytokines. P53 plays a crucial role in the
protection against DNA damage allowing cell cycle arrest,
DNA repair or apoptosis by transcriptional activation of p53
related genes such as p21 and Bax.23 Ionizing radiation pro-
duces double and single strand DNA breaks. Cells respond to
DNA photoproducts and DNA breaks by accumulation of
functionally active p53 proteins.
Upon exposure to radiation, p53 is known to sense DNA
damaged and to subsequently halt the cell cycle in the G1
phase, providing time for DNA repair. If the damage to the
genome is too serious and repair likely to fail, p53 acts as an
inducer of apoptosis.14 Consistent with this report, we ob-
served that these proteins are up-regulated in response to
irradiation-caused DNA damage leading to cell cycle arrest
to allow enough time for DNA repair. This observation is
consistent with similar study in animal model showing
stimulatory effect of UV radiation on the protein levels of
p53 and downstream effector p21.20 In a separate time-dose
study by Peter Mab et al 21 human skin was exposed to UVB
radiation and p53 expression was detection.  P53 expression
started to increase 3h after irradiation and reached a
maximum at 12h after UVB exposure. However, epidermal
sections at 36h appeared to be p53 negative or only faintly
stained. This seem to suggest p53 has a short half life of less
than 24h and is time -dose dependent. However, more
studies are needed in the future to further support this
anticipation, Further in this study, the radiation induced p21
protein was detected much sooner than PCNA, correlating
well with the expression of p53.  It seems likely that up
regulation of p21 could have been mediated via p53 pathway
by irradiation. The different time course of the expression
also supports this hypothesis.
PCNA is implicated in DNA replication and repair by
forming a sliding platform that could mediate the interaction
of numerous proteins with DNA.24 It is known that p21
binds to PCNA and inhibits PCNA function in DNA
replication.25 Therfore PCNA is regarded as an important
target for p21 as well as reliable biomarker for cell
proliferation. It has been observed that p53/p21 signal
transduction pathway plays a significant role in the
regulation of the PCNA response to ionizing radiation.26 In
view of the high affinity of PCNA to DNA strand breaks due
to the ionizing radiation27, it is logical to expect the rapid
recruitment of PCNA to ionizing radiation induced strand
breaks. In this study, we have demonstrated the induction of
PCNA after radiation in human skin cells and this induction
is dose and fraction size dependent.
The evidence from our study and clinical literature demon-
strate a significant dose and fraction size response during RT.
They also support the molecular rationale that increased
cytokines expression may serve as indicators of increased
normal tissue toxicity. The clinical research environment
presents a number of unique challenges to prospective pro-
teomics studies from sample collection to processing, storage
and analysis. There are many sources of error (delays in sam-
ple collection or processing, misinterpretation of standard
operating procedures (SOP) and so on) that can introduce a
myriad of confounding variables, which in turn will render
the resulting proteomic data inconclusive. We have consid-
ered these issues in details and study designs were carefully
drawn out to minimize the influence of extraneous envi-
ronmental factors that may affect our conclusions from these
data. In addition our principal data were derived from a single
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volunteer, thus avoided interindividual variations in the
responses to DNA damage.
Another limitation of our work is the small sample size and
limited apoptotic markers identified in skin relating to post-
mastectomy radiotherapy. Future studies with bigger sample
sizes are warranted to determine the cytokine changes after
radiation exposure and how these relate to normal tissue
radiation toxicity with greater certainty.
Conclusion
In summary, our results demonstrate the specific
up-regulation of a number of apoptotic related marker pro-
teins after irradiation and suggest that premature keratino-
cyte elimination occurs via apoptosis. Results also demon-
strated that their increase expression or activation occurs in
relation to radiation dose and fraction size. While total dose is
critical in determining the severity of skin toxicity, skin ef-
fects are more severe following fractionations schedules that
employ daily dose fractions of 5Gy or higher than follow dose
schedules using 2-2.5Gy daily.
More importantly, based on our findings, there is a potential
for the use of anti-apoptotic strategies which could be tar-
geted at various regions of the apoptotic pathway to prevent
radiation induced skin toxicity. Access of anti-apoptotic fac-
tors to the skin could possibly be delivered topically. The use
of such a target-specific approach would minimize the sys-
temic side effects of anti-apoptotic treatments. However, the
mechanisms regulating the increase in cytokines in vivo in
response to cellular damage and their role need additional
study.
Taken together, all of the experiments discussed in this study
lay the groundwork for future larger scale clinical trials
within our institution and in collaboration with other clinical
centers. Protein markers have potential as proxy indicators of
radiation sensitivity and exposure. It is hoped that the pre-
liminary work presented here will contribute to the identi-
fication of protein biomarkers that contributes not only to the
advancement of radiation biology in the long-term, but al-
lows us to make a difference in the lives of cancer patients.
The very high incidence of breast cancer partially attributable
to the ageing of their populations and the increasing use of
surgery and postoperative radiotherapy for its treatment
make the above type of study of special interest, with the side
effects of radiotherapy an increasingly important issue.
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